Findings related to cardiovascular disease and inflammation (MAP3K7 and SPSB1) could be tied to fenofibrate response, other findings are more difficult to link to the drug's mechanism (e.g., AGO1). This evidence concerns the gene AGO1 and cardiovascular disorder.